blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4268852

EP4268852 - VARIANT ADENO-ASSOCIATED VIRUSES AND METHODS OF USING [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  29.09.2023
Database last updated on 28.06.2024
Most recent event   Tooltip05.01.2024Publication of search reportpublished on 07.02.2024  [2024/06]
05.01.2024Change - classificationpublished on 07.02.2024  [2024/06]
05.01.2024Change - classificationpublished on 07.02.2024  [2024/06]
Applicant(s)For all designated states
Howard Hughes Medical Institute
4000 Jones Bridge Road
Chevy Chase, Maryland 20815-6789 / US
For all designated states
The Regents of the University of California
1111 Franklin Street
Oakland, CA 94607-5200 / US
[2023/44]
Inventor(s)01 / DUDMAN, Joshua
Virginia, 20147 / US
02 / HANTMAN, Adam
Virginia, 20147 / US
03 / LOOGER, Loren
Virginia, 20147 / US
04 / RITOLA, Kimberly
Virginia, 20147 / US
05 / SCHAFFER, David
Virginia, 20147 / US
06 / TERVO, Dougal Gowanlock Robinson
Virginia, 20147 / US
07 / VISWANATHAN, Sarada
Virginia, 20147 / US
08 / HWANG, Bum-Yeol
California, 94556 / US
09 / KARPOVA, Alla
Virginia, 20147 / US
 [2023/44]
Representative(s)Bassil, Nicholas Charles, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2023/44]
Application number, filing date23190144.815.06.2017
[2023/44]
Priority number, dateUS201662350361P15.06.2016         Original published format: US 201662350361 P
US201662404585P05.10.2016         Original published format: US 201662404585 P
[2023/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4268852
Date:01.11.2023
Language:EN
[2023/44]
Type: A3 Search report 
No.:EP4268852
Date:07.02.2024
Language:EN
[2024/06]
Search report(s)(Supplementary) European search report - dispatched on:EP10.01.2024
ClassificationIPC:C07K14/015, C12N7/01, A61K48/00
[2024/06]
CPC:
C07K14/005 (EP,EA,IL,KR,US); C07K14/015 (IL,US); A61K48/00 (EP,EA,IL,KR,US);
A61P21/00 (EP,IL); A61P21/02 (EP,IL); A61P25/00 (EP,IL);
A61P25/02 (EP,IL); A61P25/14 (EP,IL); A61P25/16 (EP,IL);
A61P25/18 (EP,IL); A61P25/28 (EP,IL); A61P27/02 (EP,IL);
C12N15/86 (IL,KR,US); C40B30/06 (IL,US); C40B40/08 (IL,US);
C12N2750/14122 (EP,EA,IL,KR,US); C12N2750/14143 (KR); C12N2750/14145 (EP,EA,IL,KR,US);
C12N2810/6027 (EP,EA,IL,KR,US); C12N2830/008 (KR); Y02A50/30 (EP) (-)
Former IPC [2023/44]A61K48/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/44]
TitleGerman:VARIANTE ADENO-ASSOZIIERTE VIREN UND VERFAHREN ZUR VERWENDUNG[2023/44]
English:VARIANT ADENO-ASSOCIATED VIRUSES AND METHODS OF USING[2023/44]
French:VIRUS ADÉNO-ASSOCIÉS VARIANTS ET PROCÉDÉS D'UTILISATION[2023/44]
Parent application(s)   TooltipEP17734575.8  / EP3472183
Fees paidRenewal fee
21.11.2023Renewal fee patent year 03
21.11.2023Renewal fee patent year 04
21.11.2023Renewal fee patent year 05
21.11.2023Renewal fee patent year 06
21.11.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2006119150  (BETH ISRAEL HOSPITAL [US], et al) [I] 1-17 * example 5 * * figure 1 *;
 [A]WO2015038958  (CALIFORNIA INST OF TECHN [US]) [A] 1-17 * table 3 * * paragraphs [0210] , [ 211] * * figure 23 *;
 [A]WO2015121501  (KING S COLLEGE LONDON [GB], et al) [A] 1-17 * page 45, paragraphs 2-4 * * page 19, paragraph 5 *;
 [E]WO2017197355  (4D MOLECULAR THERAPEUTICS INC [US]) [E] 1-17 * examples 1-3 *;
 [E]WO2018022905  (UNIV CALIFORNIA [US], et al) [E] 1-17 * example 1 *;
 [A]  - E A SALEGIO ET AL, "Axonal transport of adeno-associated viral vectors is serotype-dependent", GENE THERAPY, GB, (20130301), vol. 20, no. 3, doi:10.1038/gt.2012.27, ISSN 0969-7128, pages 348 - 352, XP055304195 [A] 1-17 * page 348, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1038/gt.2012.27
 [A]  - DOMINIK F. ASCHAUER ET AL, "Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain", PLOS ONE, (20130927), vol. 8, no. 9, doi:10.1371/journal.pone.0076310, page e76310, XP055408666 [A] 1-17 * figure 5 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0076310
 [XP]  - TERVO D GOWANLOCK R ET AL, "A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons", NEURON, (20161019), vol. 92, no. 2, doi:10.1016/J.NEURON.2016.09.021, ISSN 0896-6273, pages 372 - 382, XP029778113 [XP] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.neuron.2016.09.021
 [T]  - TERVO D GOWANLOCK R ET AL, "96: A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons", MOLECULAR THERAPY; ASGCT ANNUAL MEETING: COMPLETE LISTING OF ACCEPTED ABSTRACTS FOR PRESENTATION AT ASGCT'S 20TH ANNUAL MEETING, ACADEMIC PRESS, US; WASHINGTON, DC, USA, (20170501), vol. 25, no. 5, Suppl.1, ISSN 1525-0016, page 46, XP009500358
by applicantWO2014059154
 US2015111222
 US9518996
 US9644007
    - KASPAR et al., Mol. Ther, (20020000), vol. 5, pages 50 - 56
    - ALTSCHUL et al., Nucleic Acids Res, (19970000), vol. 25, page 3389 3402
    - FISHER et al., Nature Med, (19970000), vol. 3, pages 306 - 12
    - MANNING et al., Human Gene The, (19980000), vol. 9, pages 477 - 85
    - MAHESHRI et al., Nat. Biotechnol, (20060000), vol. 24, pages 198 - 204
    - MULLER et al., Nat. Biotechnol, (20030000), vol. 21, pages 1040 - 6
    - KOERBER et al., Mol. Ther, (20090000), vol. 17, pages 2088 - 95
    - KOERBER et al., Mol. Ther, (20080000), vol. 16, pages 1703 - 9
    - MAHESHRI et al., Nat. Biotechnol, vol. 24, pages 198 - 204
    - JANG et al., Mol. Ther, (20110000), vol. 19, pages 667 - 75
    - HE et al., Neuron, (20120000), vol. 73:35-48, pages 35 - 48
    - GUO et al., Nat. Med, (20140000), vol. 20, pages 130 - 8
    - SLAYMAKER et al., Science, (20160000), vol. 351, pages 84 - 8
    - CONG et al., Science, (20130000), vol. 339, pages 819 - 23
    - KOERBER et al., Mol. The, (20080000), vol. 16, pages 1703 - 9
    - KOERBER et al., Nat. Protocols, (20060000), vol. 1, pages 701 - 6
    - MULLER et al., Nat. Biotechnol., (20030000), vol. 21, pages 1040 - 6
    - LEGG et al., J. Comp. Neurol, (19890000), vol. 286, no. 4, pages 427 - 41
    - SCHMUEDFALLON, Brain Res, (19860000), vol. 377, pages 147 - 54
    - PAN et al., Front Neuroanat, (20100000), vol. 4, page 147
    - GERFEN et al., Neuron, (20130000), vol. 80, pages 1368 - 83
    - SAUNDERS et al., Front Neural Circuits, (20120000), vol. 6, page 47
    - CHEN et al., Nature, (20130000), vol. 499, pages 295 - 300
    - LI et al., Nature, (20150000), vol. 519, pages 51 - 6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.